How many employees are at Terumo?
TG Therapeutics, Inc. maintains a specialized biopharmaceutical workforce comprising approximately three hundred ninety-nine employees, focusing on the acquisition, development, and commercialization of innovative treatments for autoimmune and hematologic malignancies. Headquartered in New York City, the commercial-stage biopharma company directs its human assets toward clinical trial management, regulatory compliance, medical affairs, and specialized pharmaceutical marketing. Its lean organizational structure enables agile decision-making, relying heavily on experienced scientific investigators, clinical research coordinators, and targeted commercial sales teams to support patients.
Related FAQs
As of the close of the trading session on July 24, 2026, Truist Financial Corporation (TFC) stock was priced at $51.76 per share, reflecting a daily increase of 1.09%.